NASDAQ:RNAZ

Transcode Therapeutics Stock Predictions

etoro logo Buy RNAZ
*Your capital is at risk
$5.04
-0.245 (-4.64%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

RNAZ Prediction Chart

RNAZ Predictions History

Latest community submissions for RNAZ.
Predictor Target Session Target Price Result Direction Accuracy Score
Apr 8, 2025 $0.614 +37.94% $0.388 X 41.80% 0
Apr 8, 2025 $0.551 +23.71% $0.388 X 58.11% 0
Apr 8, 2025 Bullish $0.388 X 0
Apr 4, 2025 $0.650 +40.55% $0.458 X 58.22% 0
Apr 4, 2025 $0.579 +25.35% $0.458 X 73.56% 0
Apr 4, 2025 $20.00 +4 227.13% Unrealistic Excluded from avg $0.458 X 0.00% 0
Feb 10, 2025 $9.59 +3 790.83% Unrealistic Excluded from avg $11.80 X 81.28% 0
Feb 10, 2025 Bullish $11.80 V 1
Feb 6, 2025 $8.02 +3 489.05% Unrealistic Excluded from avg $11.37 X 70.55% 0
Feb 6, 2025 $8.37 +3 643.16% Unrealistic Excluded from avg $11.37 X 73.58% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for RNAZ with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT TRANSCODE THERAPEUTICS, INC.
TransCode Therapeutics
TransCode Therapeutics, Inc., a biopharmaceutical company, engages in the development and commercialization of drugs and diagnostics for treating and identifying metastatic disease. Its lead therapeutic candidate, TTX-MC138, is a preclinical stage product for the treatment of metastatic cancer. The company's products in preclinical programs include TTX-siPDL1, an siRNA-based modulator of programmed death-ligand 1; TTX-siLIN28B, an siRNA-based inh...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE